News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Immutep.
RELATED STOCKHEAD STORIES
Health & Biotech
Immutep shares are flying as Merck and Pfizer agree to test cancer drug
Health & Biotech
Revenue up but increased spending sends cancer fighter Immutep to $12.7m loss
Health & Biotech
Cancer play Immutep is branching into autoimmune diseases
Health & Biotech
Immuron sits back as US funds compete to get a piece of its gut technology
Health & Biotech
Cancer play Immutep gains 13pc after deal with US drug giant Merck
Health & Biotech
Lucy Turnbull steps down as chair of Immutep due to ‘extensive commitments’
Health & Biotech
Cancer sniper Prima BioMed rebrands to Immutep as it zeroes in on ‘immuno-oncology’
Health & Biotech
Will Lucy Turnbull-chaired Prima Biomed back a winner?
Health & Biotech
